Cellular Dynamics International Inc., a Madison developer and manufacturer of human cells, said it plans to enter clinical trials with stem cell therapies sometime between 2018 and 2020.

The cell-maker revealed its plans in an announcement that it has split its operations into two business units — one focused on developing therapies and the other focused on building the company’s research products business. Read the full story here.